Skip to Content
Merck
  • Human pancreas endocrine cell populations and activating ABCC8 mutations.

Human pancreas endocrine cell populations and activating ABCC8 mutations.

Hormone research in paediatrics (2014-06-20)
Kanetee Busiah, Virginie Verkarre, Hélène Cavé, Raphael Scharfmann, Michel Polak
ABSTRACT

Activating mutations in the ABCC8 gene encoding the KATP channel subunit SUR1 cause β-cell dysfunction with non-autoimmune diabetes mellitus in neonates or infants. We investigated whether activating ABCC8 mutations affect endocrine pancreas development. We studied a male infant with compound heterozygous ABCC8 mutations (p.Arg826Trp/p.Ile93Thr) causing neonatal diabetes mellitus. He died of ketoacidosis. Postmortem pancreas specimens were evaluated by fluorescent microscopy after immunostaining for insulin, glucagon, somatostatin, and PCNA, and Hoechst 33342 nuclear staining. We compared the findings to those in 5 age-matched controls. The number of islets was decreased and the number of single or small clusters of insulin cells increased in the patient compared to the age-matched controls. The islets in the patient had an insulin-cell core surrounded by intermingled glucagon and somatostatin cells. The insulin/Hoechst surface ratio was decreased and the glucagon/Hoechst surface ratio increased in the patient (4.3 and 8.8%, respectively) versus the controls (8.2 and 3.1%, respectively). Somatostatin surface staining was similar in the patient and controls (4 vs. 4.7%). PCNA staining was increased 3- to 3.5-fold, indicating increased insulin-cell proliferation compared to controls. Activating ABCC8 mutations impaired the balance between β and α cells in the patient, suggesting an effect on β-cell mass development.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-PCNA antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Fluorescein, for fluorescence, free acid
Sigma-Aldrich
Somatostatin, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Somatostatin, ≥97% (HPLC), powder
Somatostatin, European Pharmacopoeia (EP) Reference Standard
Fluorescein, European Pharmacopoeia (EP) Reference Standard